Back to drug list

Panzyga (IVIG)


Billing

Code: J1599

Description: INJECTION, IMMUNE GLOBULIN, INTRAVENOUS, NON-LYOPHILIZED (E.G., LIQUID), NOT OTHERWISE SPECIFIED, 500 MG

Unit: 0.5 g

Payment: $71.583

Pay quarter: Q1 2023


Medicare history

Dosage and Frequency

Calculate drug reimbursement


Total Reimbursement:

$4,552.68

(ASP: $4,294.98, Margin: $257.70)


Code:

J1599

# Units to bill:

60

Prior Authorization

Prior auth criteria for Panzyga may include but is not limited to:


1. The patient must have a diagnosis of primary immunodeficiency (PID)
2. The patient must meet the criteria for one of the following conditions:
* Common variable immunodeficiency
* X-linked agammaglobulinemia
* Severe combined immunodeficiency
* Wiskott-Aldrich syndrome
* Chronic granulomatous disease
* Hyper IgM syndrome
3. The patient must have failed to respond to or is intolerant to conventional therapy
4. The requested dose must be appropriate for the patient's weight
5. The patient must have a signed consent form indicating their understanding of the risks and benefits of treatment
6. The patient must have a negative pregnancy test if they are of childbearing potential
7. The patient must have a serum IgG level ?400 mg/dL
8. The patient must have evidence of an active infection or an increased risk of infection


Insurance prior auth guidelines:


Billable NDCs


Resources